The opinion of patients with multiple sclerosis is key to designing a tool that helps shared decision-making

by Vall d’Hebron

1 year ago
SeleccionEM., multiple sclerosis

A study, led by Vall d'Hebron, identifies what type of information patients need to develop a web platform that will be useful to them when involving- se in making decisions about their treatment.

A study shows that vaccination against COVID-19 is safe and effective for patients with Multiple Sclerosis

by Fundació Clínic per a la Recerca Biomèdica

1 year ago
Multiple Sclerosis

A team from the Hospital Clínic-IDIBAPS, in collaboration with the Hospital de Sant Pau and the Hospital Sant Joan de Déu, has carried out a study to determine whether vaccination against COVID-19 i...

Identified one of the mechanisms that cause neuronal damage in patients with multiple sclerosis

by Vall d’Hebron

3 years ago
multiple sclerosis, astrocytes

The study published in Clinical and Translational Medicine has shown that inflammation at the onset of the disease causes a change in astrocytes, a type of star-shaped cell of the central nervous syst...

ORYZON presents safety and efficacy data of vafidemstat from the Phase II SATEEN trial in multiple sclerosis at ECTRIMS-2021

by Oryzon Genomics

3 years ago
Oryzon, Vafidemstat, multiple sclerosis

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, presented today...

Rounds of funding, grants, pipeline advances, appointments and discoveries in leukemia

by Biocat

5 years ago
investment, leukemia, surgical robotics, platform, multiple sclerosis, dementia

Rounds at Ability, Elma and Vytrus and “la Caixa” grants, among the top headlines in September

IDIBELL researchers identify a new leukodystrophy in children and its potential cure

by IBEC - Institut de Bioenginyeria de Catalunya

6 years ago
childhood disease, brain, disability, DESG1, drug, multiple sclerosis

The gene that causes the disease is called DEGS1 and its defect may be counteracted with fingolimod, a drug currently used to treat multiple sclerosis

Bionure project of the GAEM's Accelerator Programme raises more than €1M via equity crowdfunding

by Parc Científic de Barcelona

8 years ago
Bionure, Capital Cell, crowdfunding, BN201, Multiple Sclerosis

With more than €1M raised, Bionure’s campaign '#estamosaesto' (‘we are this close’) is currently overfunding on the Capital Cell crowdfunding platform.These funds will be used by the company t...

IDIBAPS shares one milion euros to develop a project on Multiple Sclerosis

by IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer

8 years ago
Multiple Sclerosis, retinal neurons, Raman spectroscopy, molecular changes, (GMSI) award

The purpose of this research is to monitor molecular changes experienced by retinal neurons in patients with MS. The goal is focused on providing information that could allow, on the one hand, develop...

Diagnosis through the retina can predict the evolution of patients with Multiple Sclerosis

by Fundació Clínic per a la Recerca Biomèdica

9 years ago
Multiple Sclerosis, diagnosis, retina, optical coherence tomography

A study led by IDIBAPS researchers has shown the usefulness of optical coherence tomography (OCT), a diagnostic imaging technique widely used in ophthalmology, for monitoring patients with multiple sc...

A new gene involved in Multiple Sclerosis is discovered

by Universidad del País Vasco

9 years ago
ANKRD55, 5q11 chromosome, multiple sclerosis

The Ikerbasque researcher Koen Vandenbroeck, who heads the Neurogenomiks laboratory which reports to the Achucarro centre and the UPV/EHU-University of the Basque Country, together with other national...

New tools for the diagnosis of multiple sclerosis in its early stages

by Vall d’Hebron

9 years ago
Multiple sclerosis, proteins, cerebrospinal fluid, diagnostics

After analyzing each of the samples from this study, the researchers have identified the proteins that can predict the risk of developing multiple sclerosis. With these data they have also built a sta...

Starts the clinical trial of a pioneering therapy for treating Multiple Sclerosis

by Parc Científic de Barcelona

10 years ago
Neuromyelitis Optica, multiple sclerosis, antigen-specific dendritic cell therapy

The clinical trial will be conducted July through December 2015 in 12 patients with multiple sclerosis. Subsequently trials will take place in Europe, and waiting inmid-2018 to get to the clinic if th...